Axsome Therapeutics, Inc. (AXSM) Financials

$137.75

north_east
$8.65 (6.7%)
Day's range
$128.39
Day's range
$139.13
$400M$400M$200M$200M$0$0-$200M-$200M-$400M-$400MEarning201820182019201920202020202120212022202220232023202420240%0%-100%-100%-200%-200%-300%-300%-400%-400%Profit Margin
Profit Margin
Revenue
Earnings

AXSM Income statement / Annual

Last year (2024), Axsome Therapeutics, Inc.'s total revenue was $385.69 M, an increase of 42.53% from the previous year. In 2024, Axsome Therapeutics, Inc.'s net income was -$287.22 M. See Axsome Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $385.69 M $270.60 M $50.04 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $33.30 M $26.07 M $5.20 M $1.16 M $77,718.00 $37,330.00 $48,935.00 $42,557.00 $20,484.00 $3,542.00
Gross Profit $352.39 M $244.54 M $44.84 M -$1.16 M -$77,718.00 -$37,330.00 -$48,935.00 -$42,557.00 -$20,484.00 -$3,542.00
Gross Profit Ratio 0.91 0.9 0.9 0 0 0 0 0 0 0
Research and Development Expenses $187.08 M $97.94 M $57.95 M $58.06 M $70.24 M $53.65 M $23.50 M $19.96 M $21.20 M $6.78 M
General & Administrative Expenses $0.00 $222.82 M $123.95 M $66.65 M $28.90 M $13.60 M $9.35 M $7.21 M $6.34 M $2.42 M
Selling & Marketing Expenses $0.00 $100.30 M $35.30 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $411.36 M $323.12 M $159.25 M $66.65 M $28.90 M $13.60 M $9.35 M $7.21 M $6.34 M $2.42 M
Other Expenses $34.52 M $55.29 M $4.14 M $0.00 -$53,578.00 -$139,448.00 $217,418.00 $207,114.00 $474,279.00 $0.00
Operating Expenses $632.95 M $476.36 M $221.34 M $124.71 M $99.09 M $67.11 M $32.63 M $26.96 M $27.07 M $9.20 M
Cost And Expenses $666.26 M $502.43 M $226.54 M $124.71 M $99.09 M $67.11 M $32.63 M $26.96 M $27.07 M $9.20 M
Interest Income $0.00 $0.00 $7.33 M $5.70 M $2.57 M $1.24 M $0.00 $0.00 $0.00 $914,952.00
Interest Expense $6.57 M $6.45 M $7.33 M $5.70 M $2.57 M $1.24 M $1.13 M $1.34 M $132,424.00 $914,952.00
Depreciation & Amortization $0.00 $6.83 M $5.56 M $1.16 M $77,718.00 $37,330.00 $48,935.00 $42,557.00 $20,484.00 $3,542.00
EBITDA -$280.56 M -$224.99 M -$174.23 M -$123.55 M -$99.06 M -$67.21 M -$32.58 M -$27.77 M -$27.52 M -$9.19 M
EBITDA Ratio -0.73 -0.83 -3.42 0 0 0 0 0 0 0
Operating Income Ratio -0.73 -0.86 -3.53 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$6.57 M -$6.45 M -$7.33 M -$5.70 M -$3.81 M -$1.24 M $1.66 M -$1.78 M $341,855.00 -$1.36 M
Income Before Tax -$287.13 M -$238.28 M -$187.13 M -$130.40 M -$102.90 M -$68.35 M -$30.97 M -$28.94 M -$27.20 M -$10.56 M
Income Before Tax Ratio -0.74 -0.88 -3.74 0 0 0 0 0 0 0
Income Tax Expense $85,000.00 $960,000.00 $10.63 M $4.54 M $2.49 M $1.34 M $3.01 M $1.30 M $586,219.00 $1.36 M
Net Income -$287.22 M -$239.24 M -$197.77 M -$134.94 M -$105.39 M -$69.69 M -$30.97 M -$28.94 M -$27.20 M -$10.56 M
Net Income Ratio -0.74 -0.88 -3.95 0 0 0 0 0 0 0
EPS -5.99 -5.27 -4.86 -3.59 -2.83 -2.05 -1.15 -1.27 -1.42 -0.88
EPS Diluted -5.99 -5.27 -4.86 -3.59 -2.83 -2.05 -1.15 -1.27 -1.42 -0.88
Weighted Average Shares Out $47.91 M $45.43 M $40.66 M $37.62 M $37.21 M $34.02 M $26.88 M $22.76 M $19.15 M $11.95 M
Weighted Average Shares Out Diluted $47.91 M $45.43 M $40.66 M $37.62 M $37.21 M $34.02 M $26.88 M $22.76 M $19.15 M $11.95 M
Link